Tag results:

tumor associated macrophages

Multifunctional Silica Nanocomposites Prime Tumoricidal Immunity for Efficient Cancer Immunotherapy

[Journal of Nanobiotechnology] Scientists developed a novel nanocomposite, polyethyleneimine-modified dendritic mesoporous silica nanoparticles loaded with microRNA-125a to synergistically enhance immune response and immunosuppression reversion, ultimately generating a tumoricidal environment.

XBP1 Regulates the Protumoral Function of Tumor-Associated Macrophages in Human Colorectal Cancer

[Signal Transduction and Targeted Therapy] Macrophages are among the most abundant immune cells in colorectal cancer. Differentially expressed genes were found to be enriched in unfolded protein response/endoplasmic reticulum stress response processes, and XBP1 splicing/activation was specifically observed in tumor-associated macrophages.

Targeting of the Tumor Immune Microenvironment by Metformin

[Journal of Cell Communication and Signaling] The authors explain the basic mechanisms for the interactions and communications between immunosuppressive, anti-tumoral, and cancer cells within the tumor microenvironment (TME), and discuss the modulating effects of metformin on various cells and secretions in the TME.

The Interaction of Helicobacter pylori with Cancer Immunomodulatory Stromal Cells: New Insight into Gastric Cancer Pathogenesis

[Seminars in Cancer Biology] The authors discuss the interplay between H. pylori and tumor-supportive cells, including mesenchymal stem cells, cancer-associated fibroblasts, tumor-associated macrophages, and myeloid derived-suppressor cells in gastric cancer.

PI3Kγδ Inhibitor plus Radiation Enhances the Antitumor Immune Effect of PD-1 Blockade in Syngenic Murine Breast Cancer and Humanized Patient-Derived Xenograft Model

[European Journal of Cancer] Murine breast cancer cells were grown in both immune-competent and -deficient BALB/c mice, and tumors were irradiated by three fractions of 24 Gy. A PD-1 blockade and a phosphoinositide 3-kinase (PI3K)γδ inhibitor were then administered every other day for two weeks.

Macrophages and Cancer Stem Cells: A Malevolent Alliance

[Molecular Medicine] In view of the recent success in oncology obtained by stimulating the immune system, scientists discuss some macrophage-targeted therapeutic strategies that may also affect the CSCs and interrupt their malevolent alliance.

Popular